|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/22 | |
| A61K 9/20 | |||
| A61K 38/21 | |||
| A61K 47/34 |
| (11) | Number of the document | 2552422 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11763095.4 |
| Date of filing the European patent application | 2011-04-04 | |
| (97) | Date of publication of the European application | 2013-02-06 |
| (45) | Date of publication and mention of the grant of the patent | 2017-09-06 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/KR2011/002335 |
| Date | 2011-04-04 |
| (87) | Number | WO 2011/122923 |
| Date | 2011-10-06 |
| (30) | Number | Date | Country code |
| 20100030577 | 2010-04-02 | KR |
| (72) |
KIM, Dae Jin, KR
KIM, Min Young, KR
KIM, Jin Sun, KR
HONG, Sung Hee, KR
JUNG, Sung Youb, KR
KWON, Se Chang, KR
|
| (73) |
Hanmi Science Co., Ltd.,
550 Dongtangiheung-ro Dongtan-myeon Hwaseong-si, Gyeonggi-do 445-813,
KR
|
| (54) | LONG-ACTING INTERFERON BETA FORMULATION USING IMMUNOGLOBULIN FRAGMENT |
| LONG-ACTING INTERFERON BETA FORMULATION USING IMMUNOGLOBULIN FRAGMENT |